Vanda Pharmaceuticals reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Akebia Therapeutics 0 0 Mar/2025
Anika Therapeutics 0 0 Mar/2025
AstraZeneca USD 1.18 0.56 Mar/2026
Bristol-Myers Squibb 4.12 3.9 Mar/2026
Eli Lilly 0.58 0.16 Dec/2025
Enanta Pharmaceuticals 0 0 Mar/2025
Esperion Therapeutics 0 0 Mar/2025
Heron Therapeutics 0 0 Mar/2025
J&J 2.16 0.34 Mar/2026
Lexicon Pharmaceuticals 0 0 Mar/2025
Merck 2.76 0.36 Mar/2026
Minerva Neurosciences 0 0 Mar/2025
Novartis 2.9 0.22 Dec/2025
Pfizer 6.91 0.33 Dec/2025
Puma Biotechnology 0 0 Mar/2025
Sangamo BioSciences 0 0 Mar/2025
Sanofi 4.98 0.24 Mar/2026
Takeda 4.08 0.46 Dec/2025
Vanda Pharmaceuticals 0 0 Mar/2025